A new coronavirus vaccine heading to India was developed by a small team in Texas. It expects nothin

[LetMyPeopleVote]

Dr. Hotez is amazing. He spoke to my temple during High Holy Days services

Link to tweet

For some vaccine developers, the coronavirus pandemic has had a silver lining in billions of dollars in profits. But a new vaccine rolling out soon in India is taking the opposite approach: Its developers are getting zilch.

“We’re not trying to make money,” said Peter Hotez of the Texas Children’s Hospital’s Center for Vaccine Development. “We just want to see people get vaccinated.”

On Tuesday, the Indian government granted emergency approval to a vaccine manufactured by the Hyderabad-based company Biological E. This “second generation” coronavirus vaccine was developed by Hotez and his longtime collaborator Maria Elena Bottazzi. It was then licensed to Biological E. through a commercialization team at Baylor College of Medicine in Houston, where both developers also work.

Biological E. has ambitious plans to produce more than 1 billion doses of the vaccine in 2022. Hotez and Bottazzi won’t personally get a penny from it, but their employer Baylor College will get a fee.

[NQAS]

1. That's great

What’s the college’s “fee?”

[LetMyPeopleVote]

2. "We're not trying to make money. We just want to see people get vaccinated."

Link to tweet

[dalton99a]

3. Kick